Grey Hair Cure
Today, we begin a series of articles on new companies entering the hair growth industry. One of these companies, Eirion Therapeutics, has treatments for androgenic alopecia as well as hair graying in their pipeline. Topadur Pharma M119 Based in Switzerland, Topadur Pharma is a clinical stage pharmaceutical company with a focus on the cGMP (cyclic…
Read More
RiverTown Therapeutics has engaged in an academic research collaboration to validate an effect of RT1640 that has already been observed in humans – gray hair reversal. A collaboration has begun between RiverTown Therapeutics and The University of Alabama at Birmingham with well-known hair pigment researcher Dr. Melissa Harris. You may remember Dr. Melissa Harris as…
Read More
A research team from the University of Alabama at Birmingham have identified a gene in mice that can lead to skin wrinkles, gray hair, and hair loss….or the reversal of such disorders. Keshav Singh PhD and colleagues have discovered a genetic mutation affecting mitochondria to be a major regulator of health and the aging process.…
Read More
Earlier this month, research coming out of the NIH and the University of Alabama made headlines for uncovering a piece of the biological puzzle which is the process of hair graying. The team behind the study determined that the immune system is highly involved in the proces of achromotrichia (hair graying) and that the transcription…
Read MoreHello Everyone, Welcome to a new edition of Weekly Thoughts. I’ve got some details to share on how things are going at HairClone these days, as well as notions on two promising studies on genes involved in hair growth. One of the studies has had the internet ablaze lately with KROX talk. It’s surely a…
Read More
I’m very happy to be bringing you all an incredible exclusive on Follicle Thought. This week, David Weinstein, MD, PhD of RiverTown Therapeutics Inc. reached out to me to share some amazing photo results of his new compound RT1640. Below you will find photographs of a 60+ year old woman and a 42 year old…
Read MoreHey everybody, welcome to another installment of Weekly Thoughts. This week we get an encouraging update about the logistics of Shiseido’s trial and more information about the RiverTown Therapeutics Inc. compound. Shiseido Closer to Trial News was finally released this week about Shiseido’s upcoming trial in Japan using Replicel’s RCH-01 technology. Shiseido acquired an exclusive…
Read MoreHello Everyone, Welcome to another edition of Weekly Thoughts. This edition features a presentation update on the JAK inhibitor therapies for hair growth and the announcement of a new startup/treatment for hair growth that is also claimed to restore hair pigment. Wowzas. Let’s take a look. Aclaris Therapeutics Jeffries Presentation Acalaris Therapeutics CEO Dr. Neal…
Read MoreHello Everybody, It’s nice to be back here with you all for another installment of Weekly Thoughts. I’m personally excited about several items discussed in this edition. Let’s see what’s going on in the hair world this week. BiologicsMD New Site Layout With Pipeline BiologicsMD, a biotech startup which is affiliated with the University of…
Read MoreHello Everybody, As always, it is nice to be here with you to report on the latest hair growth related news for this edition of Weekly Thoughts. Major Gene Study All About Follicles A study lead by Kaustubh Adhikari of University College London has mapped out a gene analysis for some of the major characteristics…
Read More